Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by SironaInvestoron Oct 28, 2022 9:05am
129 Views
Post# 35055396

RE:Who is

RE:Who is
I'm pretty sure that Sirona failed again here as Elanco decided to contract with another party. But as we all know, Howard will find something new with unmet need which brings him a smile in his bloody face again. :-) Guys, we all have lost and made ourselves the wrong Due diligence. This company with the inexperienced Canadian Management will survive, I'm pretty sure, but the hundreds of millions in regards to a potential fair company value will never appear!!!!!! We all trust a doctor who finally got nice salaries from us. We wrote mails to the vice President operations in order to get at least some trustful information. The same warmed bu.llshit has been presented from her. Nobody has ever got a feeling what Mr. tian has done for this company. Guys, my guess is we will see the 0,02 cent quickly. Trust is completely lost!!! No institutional investors, no reorganization, no new CEO, no pet deal with Elanco, no significant upfront with allergan as promised. Only lies since almost a decade!! I only can see some movements if Canadian shareholder's take legal advice and claim money back. There should be some possibilities I believe. I'm so pissed off and also frustrated about m own stupid approach to invest into this bloody company!!!!!
<< Previous
Bullboard Posts
Next >>